Skip to main content
Day.News — Local News. Real Community.
COLUMBUS DAY NEWS
Local News. Real Community.
health
1 min read

CDC Study Finds Bird Flu Strains May Show Increased Potential for Human Infection

A Centers for Disease Control and Prevention study indicates some North American bird flu strains possess characteristics that could heighten their capacity to infect humans. The research also suggests a possible increase in human-to-human transmission potential. Further investigation is underway.

06/11/2026 · Ohio edition

Advertisement

Advertisement

Atlanta, Ga. — Research from the Centers for Disease Control and Prevention suggests particular strains of North American avian influenza A H7 viruses exhibit properties that could enhance their ability to infect humans.

The CDC study also indicates a potential increase in the viruses' capacity to spread between humans. Scientists are conducting further research to assess the implications of these findings.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

How do you feel about this story?

NA

National Desk

Trust 3.1102445 articles8,231,170 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

Join the conversation

Sign in to share your thoughts, reply to readers, and like comments.

Sign in to comment
Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Trending stories will appear here.

More from Ohio

No other local stories are available right now.

Events & Things to Do

Read section →

Upcoming events will appear here.

Advertisement

Advertisement

Keep Reading

Related Stories

More health stories from Ohio

health

Pennsylvania Reports State's Largest Measles Outbreak in Three Decades

Pennsylvania is experiencing its most extensive measles outbreak in 30 years. The current situation marks the largest cluster of cases seen in the state over three decades.

Read Story →
health

Trump Administration Finalizes Healthcare Transparency Rule

The Trump administration has issued a final rule regarding transparency in healthcare coverage. Health and Human Services Secretary Robert F. Kennedy Jr. stated the regulation offers a 'clear view of what healthcare actually costs.' This initiative seeks to increase consumer understanding of medical expenses.

Read Story →
health

GLP-1 Medications See Increased Use, Spur Research into New Applications

GLP-1 medications are now used by an estimated one in eight Americans. Researchers continue to investigate new potential applications for these drugs. The expansion in use prompts further questions and research.

Read Story →
health

Bipartisan Concern Grows Over Pharmacy Benefit Managers

Republicans and Democrats alike are directing scrutiny toward pharmacy benefit managers, or PBMs. Tennessee and Arkansas have already implemented regulations targeting these healthcare companies. This convergence of political and public opinion highlights increasing pressure on PBM operations.

Read Story →
health

Voters Seek Clear Policy Details, Economic Security from Candidates

Undecided voters express a desire for candidates to provide specific plans on issues affecting their daily lives. Economic stability and healthcare costs rank among their top concerns. Voters indicate they are looking for substantive proposals rather than broad ideological statements.

Read Story →
health

Eli Lilly's EloraTZP Shows Greater Weight and A1C Reduction in Phase 2b Trial

Eli Lilly's experimental drug EloraTZP, a combination of eloralintide and tirzepatide, demonstrated superior weight loss and A1C reduction compared to tirzepatide 15 mg in a 48-week Phase 2b study. Participants taking EloraTZP lost significantly more weight and saw greater improvements in their blood sugar levels.

Read Story →
Scroll for more stories